Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol Plus Tiotropium vs Formoterol in Stable COPD
NCT00680056Phase 4Completed
- Sponsor
- Federal University of São Paulo
- Start
- Nov 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Percentage Change in Exercise Tolerance From Baseline at 2 weeks. Started Nov 2007; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00680056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680056.